UNSPSC 51162318: Acetaminophen/dextromethorphan/guaifenesin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162318 Acetaminophen/dextromethorphan/guaifenesin is a Commodity code that in recent state and local practice covers pharmaceutical products beyond its narrow nominal scope — specifically generic multi-source pharmaceuticals, over-the-counter remedies, and emergency medical supplies such as naloxone and drug deactivation systems. State and local governments soliciting under this code include county health departments and state cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The work involves competitively procuring finished pharmaceutical products, typically through fixed-fee or tiered-pricing agreements with quarterly or ongoing delivery to designated health facilities, with vendors managing logistics, compliance with cGMP and drug-supply-chain regulations, and insurance coverage including commercial general liability and professional liability.

Recent activity spans Florida and the upper Midwest. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly delivery to its Community Health Building in Sanford; the contract carries a two-year initial term with a one-year renewal option and was potentially FEMA-funded. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 to establish multiple generic pharmaceutical and OTC product contracts across participating state and local facilities including Oregon; proposals were due March 26, 2026, with awards effective July 1, 2026, and vendors required to maintain relationships with AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co. as authorized wholesalers and to comply with a 3 percent administrative fee on all contract purchases.